Treatment of Severe and Fulminant Clostridioides difficile Infections

Gastroenterology Clinics of North America · Published 2026-06-22 · DOI 10.1016/j.gtc.2026.05.006

Authors (4)

R. Benson Weyant, Georgiana Emmanuela Gîlcă-Blanariu, Monika Fischer, Dina Kao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Weyant, R., Gîlcă-Blanariu, G., Fischer, M., et al. (2026). Treatment of Severe and Fulminant Clostridioides difficile Infections. Gastroenterology Clinics of North America. https://doi.org/10.1016/j.gtc.2026.05.006

Related articles

• Food and Drug Administration–Approved Fecal Microbiota–Based Therapies for Recurrent Clostridioides difficile Infection · Gastroenterology Clinics of North America · 2026 · Same journal
• Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis Syndrome · Gastroenterology Clinics of North America · 2025 · Same journal
• Focus on Managing Pediatric Nutritional Problems into Adulthood · Gastroenterology Clinics of North America · 2025 · Same journal
• Pediatric Nutrition · Gastroenterology Clinics of North America · 2025 · Same journal
• Advancing Pediatric Nutrition: Achievements, Challenges, and Opportunities · Gastroenterology Clinics of North America · 2025 · Same journal
• Non-Severe Clostridium difficile Infection · Gastroenterology Clinics of North America · 2026 · Same journal
• Celiac Disease · Gastroenterology Clinics of North America · 2025 · Same journal
• Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection · Gastroenterology Clinics of North America · 2026 · Same journal
• Complex Care Across the Continuum · Gastroenterology Clinics of North America · 2025 · Same journal
• The Changing Epidemiology of Clostridioides difficile Infection · Gastroenterology Clinics of North America · 2026 · Same journal